CoChat

Glyburide Compared to Insulin for the Treatment of Gestational Diabetes Mellitus: A Cost Analysis

Goetzl, Laura, Wilkins, Isabelle · 2002 · Journal of Perinatology

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Objective To compare the costs associated with glyburide compared to insulin for the treatment of gestational diabetes unresponsive to dietary therapy. Study design A cost model was designed. The model excluded costs that were identical for both treatment arms, such as the cost of monitoring glucose control. Insulin treatment costs included average wholesale drug costs, wholesale delivery costs (syringes, alcohol pads), and costs of office staff educating patients. Glyburide costs were based on average wholesale drug costs. Downstream costs of potential inpatient evaluation for hypoglycemia were included in the model. Results In our baseline model, glyburide was significantly less costly than insulin for the treatment of gestational diabetes. The average cost saving per patient based on wholesale drug costs and hospital costs was US$165.84. Actual retail drug savings and hospital charge savings are potentially considerably greater. The strongest determinant of cost savings was medication cost. The model was less sensitive to the one-time costs of inpatient treatment and patient education. Conclusion Glyburide is less costly than insulin for the treatment of gestational diabetes. Cost models can be useful to physicians deciding between two equally efficacious medications, allowing them to incorporate information about their individual practice styles with a complex balance of cost implications.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.jp.7210759

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 6 references

Cited by

See all 54

Metadata

Authors
Goetzl, L., & Wilkins, I.
Affiliations
Baylor College of Medicine (US)
Venue
Journal of Perinatology
Published
2002-06-27
Volume
22
Issue
5
Pages
403-406
ISSN
  • 0743-8346 (ISSN-L)
  • 1476-5543
OpenAlex
W2061072286
Cited by
54
References
6
Citations by year
2024: 1 · 2023: 1 · 2022: 11 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 1 · 2015: 4 · 2014: 3 · 2013: 3 · 2012: 1
FWCI
1.13
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Journal of Perinatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
gestational diabetes mellitus, glibenclamide, insulin, cost comparison, cost model, hypoglycemia, drug costs, patient education, hospital costs
MeSH terms
Costs and Cost Analysis, Female, Glyburide, Hospitalization, Humans, Hypoglycemic Agents, Insulin, Pregnancy, Texas, Diabetes, Gestational, Hospital Charges, Models, Economic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glyburide Compared to Insulin for the Treatment of Gestational Diabetes Mellitus: A Cost Analysis. https://app.cochat.ai/papers/10.1038/sj.jp.7210759
The paper
Goetzl, L., & Wilkins, I. (2002). Glyburide Compared to Insulin for the Treatment of Gestational Diabetes Mellitus: A Cost Analysis. Journal of Perinatology. https://doi.org/10.1038/sj.jp.7210759

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.